1961
|
|
|
Cholecystokinin |
- |
Anorexia, Catalepsy, Central nervous system cancer, Cholecystolithiasis, Digestive system disease, Dyskinesia, drug-induced, Gallstones, Gastric ulcer, Gastrointestinal disease, Glioblastoma, Glioma, Hyperkinesia, Liver disease, Metabolic syndrome, Pancreatitis, Schizophrenia, Seizures, Diabetes mellitus type 2View all (3 more) |
1962
|
|
|
Cholecystokinin A receptor |
CCK-1R, CCK-A, CCK1-R, CCK1R, CCKRA |
|
1963
|
|
|
Cholecystokinin B receptor |
CCK-2R, CCK-B, CCK2R, GASR |
Alzheimer disease, Central nervous system cancer, Duodenal ulcer, Gastric ulcer, Gastroesophageal reflux disease, Glioblastoma, Glioma, Hyperalgesia, Obsessive-compulsive disorder, Ocular sarcoidosis, Panic disorder, Peptic ulcer disease, Willis-ekbom disease, Substance abuse |
1964
|
|
|
C-C motif chemokine ligand 1 |
I-309, P500, SCYA1, SISe, TCA3 |
|
1965
|
|
|
C-C motif chemokine ligand 11 |
SCYA11 |
|
1966
|
|
|
C-C motif chemokine ligand 13 |
CKb10, MCP-4, NCC-1, NCC1, SCYA13, SCYL1 |
|
1967
|
|
|
C-C motif chemokine ligand 14 |
CC-1, CC-3, CKB1, HCC-1, HCC-1(1-74), HCC-1/HCC-3, HCC-3, MCIF, NCC-2, NCC2, SCYA14, SCYL2, SY14 |
|
1968
|
|
|
C-C motif chemokine ligand 15 |
HCC-2, HMRP-2B, LKN-1, LKN1, MIP-1 delta, MIP-1D, MIP-5, MRP-2B, NCC-3, NCC3, SCYA15, SCYL3, SY15 |
|
1969
|
|
|
C-C motif chemokine ligand 16 |
CKb12, HCC-4, ILINCK, LCC-1, LEC, LMC, Mtn-1, NCC-4, NCC4, SCYA16, SCYL4 |
|
1970
|
|
|
C-C motif chemokine ligand 17 |
A-152E5.3, ABCD-2, SCYA17, TARC |
|